Sorrento Therapeutics Inc (OTC Pink - Current Information:SRNEQ)
| 0.33 Delayed Data As of Jun 06 |  +0.0132 / +4.17%Today’s Change | 0.16 Today|||52-Week Range 3.09 | -62.75% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 4.6M | 8.2M | 151.9M | 21.2M | |
| Cost of Goods Sold | 737.0K | 811.0K | 3.9M | 1.0M | ||
| Depreciation And Amortization | 2.4M | 2.9M | 7.1M | 9.1M | ||
| Operating Expenses | Gross Income | 1.5M | 4.5M | 140.8M | 11.1M | |
| General Expenses | 51.5M | 64.4M | 88.5M | 140.6M | ||
| Research And Development | 31.3M | 42.2M | 55.5M | 77.0M | ||
| Total Operating Expenses | 54.6M | 68.1M | 99.5M | 150.7M | ||
| Non-Operating Expenses | Operating Income | -50.0M | -59.9M | 52.3M | -129.5M | |
| Extraordinary Credit | 0.00 | 13.6M | 0.00 | 2.8M | ||
| Extraordinary Charge | -27.4M | -45.2M | -31.3M | -29.0M | ||
| Pre-Tax Equity Earnings | -4.0M | 435.0K | -- | -- | ||
| Interest Expense On Debt | 1.7M | 1.6M | 5.0M | 57.6M | ||
| Equity In Earnings | -- | -- | -40.2M | -5.0M | ||
| Other Expenses | 69.3M | 27.5M | -1.0M | -1.4M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -13.8M | -64.8M | 15.3M | -213.8M | |
| Income Taxes | -36.3M | -896.0K | -36.0M | -6.3M | ||
| Minority Interest | -4.3M | -3.0M | -2.0M | -9.0M | ||
| Net Income | -45.8M | -60.9M | 9.1M | -203.5M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 36.9M | 50.4M | 69.7M | 106.2M | |
| Shares To Calculate EPS Diluted | 36.9M | 50.4M | 70.4M | 106.2M | ||
| Earnings Per Share | EPS | -$1.24 | -$1.21 | $0.13 | -$1.92 | |
| EPS Diluted | -$1.24 | -$1.21 | $0.13 | -$1.92 | ||
